Position paper 15 February 2021

Global Principles on Incentivizing Antibiotic R&D


Now, more than ever, we need to accelerate the creation of a vibrant and sustainable innovation ecosystem to support R&D for new antibiotics and other antimicrobials addressing pathogens prioritized by leading public health bodies.

In this position paper we outline what the innovative pharmaceutical industry believes are priority policy actions for governments to take to enable sustainable innovation against AMR.